IL-7

IL-7 Overview

English NameInterleukin-7Approved Drugs0
Drugs in Clinical Trials5Target SynonymInterleukin 7,IL7
Highest Development StagePhase 1 Clinical
English NameInterleukin-7
Target SynonymInterleukin 7,IL7
Approved Drugs0
Drugs in Clinical Trials5
Highest Development StagePhase 1 Clinical

IL-7 Product List

  • Product Category

    Protein (11)Antibody (1)Kits (2)

  • Product Status

    Launched (14)

  • Species

    Human (11)Mouse (2)Cynomolgus (1)

  • Tag

    Tag Free (8)Fc Tag (1)His Tag (2)- (3)

  • Conjugate

    Unconjugated (12)- (2)

IL-7 Background

Interleukin 7 is also known as IL7, IL-7, and is a hematopoietic growth factor secreted by stromal cells in the red marrow and thymus. It is also produced by keratinocytes, dendritic cells, hepatocytes, neurons, and epithelial cells, but is not produced by lymphocytes. IL-7 stimulates the differentiation of multipotent (pluripotent) hematopoietic stem cells into lymphoid progenitor cells, It also stimulates proliferation of all cells in the lymphoid lineage (B cells, T cells and NK cells). It is important for proliferation during certain stages of B-cell maturation, T and NK cell survival, development and homeostasis. IL-7 is a cytokine important for B and T cell development. This cytokine and the hepatocyte growth factor (HGF) form a heterodimer that functions as a pre-pro-B cell growth-stimulating factor. IL-7 binds to the IL-7 receptor, a heterodimer consisting of Interleukin-7 receptor alpha and common gamma chain receptor. Il-7 promotes hematological malignacies (acute lymphoblastic leukemia, T cell lymphoma). Elevated levels of IL-7 have also been detected in the plasma of HIV-infected patients. IL-7 as an immunotherapy agent has been examined in many pre-clinical animal studies and more recently in human clinical trials for various malignancies and during HIV infection. IL-7 could also be beneficial in improving immune recovery after allogenic stem cell transplant.

IL-7 Synonyms

IL7,Interleukin-7

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Anti-GPC3 chimeric antigen receptor T cell therapy (Hunan Zhaotai Yongren Biotech/Guangdong Zhaotai Invivo Biomedicine)Phase 1 ClinicalGuangdong Zhaotai Invivo Biomedicine Co Ltd, Hunan Zhaotai Yongren Biotech Co LtdCarcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung
Details
HCW-9206HCW-9206Phase 1 ClinicalHCW Biologics IncLeukemia, Myeloid, Acute; Solid tumours
Details
ADP-TILIL7ADP-TILIL7Phase 1 ClinicalAdaptimmune Therapeutics PlcMelanoma
Details
GSK-3888130-BGSK3888130B; GSK-3888130; GSK-3888130-BPhase 1 ClinicalGlaxosmithkline PlcColitis, Ulcerative; Multiple Sclerosis
Details
BNT-152BNT-152Phase 1 ClinicalBiontech SeSolid tumours
Details

Product Reviews

  • Overview
  • Product List
  • Product Reviews
  • Clinical Drug Information
Contact Us

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8